New Delhi, 24 September 2025: Sony India proudly announces the launch of its Biotechnology Division, marking a significant foray into the life science sector with a focus on innovative flow cytometry products. In a major milestone, AIIMS Delhi has adopted Sony’s flagship ID7000 Spectral Cell Analyzer for advanced oncoimmunology research, underscoring Sony’s role in enabling world-class medical research in India. Additionally, IISER Bhopal and MedGenome have integrated the MA900 cell sorter system into their research workflows. This strategic expansion highlights Sony’s commitment to fostering scientific advancements and empowering researchers to drive ground-breaking discoveries. Sony India has added a new business for Life Science under the Professional Solutions Group in 2024.
“As the Indian life sciences market grows, Sony India is well-positioned to seize new opportunities and drive innovation. With its cutting-edge solutions, Sony India aims to support researchers and scientists in making groundbreaking discoveries in areas like immunology, cancer research, and regenerative medicine. Sony India also has a pipeline of new products that will further enhance research capabilities in the country.” says Daijiro Nakano, Deputy Managing Director, Sony India
Pioneering Spectral Cytometry Technology: Sony introduced the world’s first commercially available spectral cytometer in 2012, transforming the field of flow cytometry. Today, spectral cytometry is a vital tool. It empowers scientists to gain deep insights into complex cellular systems, identify rare cell subsets, and generate high-parameter data with ease.
Entering the Indian Market: Sony India launched its spectral cytometry products at the IMMUNOCON Conference 2024 at IISc Bangalore. This brought cutting-edge technology to Indian researchers and scientists. The launch marks a significant milestone in Sony India’s commitment to advancing life sciences research in the country.
Advanced Flow Cytometry Solutions: Sony India’s Biotechnology Division offers a comprehensive portfolio of cutting-edge flow cytometry instruments, including:
- ID7000 Spectral Cell Analyzer: This high-parameter system is designed to deliver unparalleled insights into heterogeneous cell populations. It offers exceptional sensitivity for detecting rare and subtle cellular events.
- SA3800 Spectral Cell Analyzer: Enhances sensitivity and streamlines application design, workflow, and analysis, surpassing conventional flow cytometers in performance and versatility.
Innovative Cell Sorting Solutions
- MA900 Multi-Application Cell Sorter: A versatile and high-performance system supporting 12 fluorescence parameters and 4-way sorting, featuring patented microfluidic chip design and advanced automation technologies.
- FP7000 Spectral Cell Sorter: Engineered for reliable, high-performance spectral cell sorting.
- SH800S Cell Sorter: Delivers efficient and precise cell sorting.
In 2024, Sony SH800 user David Baker was awarded the Nobel Prize in Chemistry 2024 for computational protein design and protein structure prediction. Similarly, in 2020, Emmanuelle Charpentier and Jennifer A. Doudna, users of the Sony SH800, were awarded the Nobel Prize in Chemistry for the development of a method for genome editing.
Sony’s patented technology portfolio underpins their leadership in spectral flow cytometry by combining optics, microfluidics, and digital analysis, enabling highly multiplexed, sensitive, and robust instruments for cell analysis and sorting applications. For example, FlowPoint™ core stability is an innovative Sony technology that leverages principles from Sony’s expertise in optical disc technology and hydrodynamic focusing to monitor and control the stability of the core fluid stream optically to ensure high resolution and reproducible flow cytometry data in spectral cytometers.